Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on MoonLake Immunotherapeutics (NASDAQ:MLTX) while keeping ...

In a report released on May 27, Jason Butler from Citizens JMP reiterated a Buy rating on Zevra Therapeutics, Inc.

On May 23, analyst Joseph Quatrochi from Wells Fargo maintained a Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) while keeping the price target of $200. The reiteration comes after the company ...

We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at where Sarepta Therapeutics Inc. (NASDAQ:SRPT) stands against other stocks ...